Mitchell, Peter G. http://orcid.org/0000-0001-5056-8321
Bright, Corina A.
Bright, Daniel R.
Srivastava, Shalini N.
Raote, Sonal S.
Kumar, Santosh
Article History
Received: 14 March 2022
Accepted: 15 May 2022
First Online: 22 June 2022
Declarations
:
: DB and CB have ownership in Interpath Pty LTD. PGM is employed as a consultant for Interpath Pty LTD and also provides consulting to Nordic Bioscience, Boehringer Ingelheim, Cocoon Biotech and MedinCell. PGM holds stock in Pfizer and Eli Lilly. SS and SR are employees of Vedic. SK is an independent consultant biostatistician.
: An independent ethics committee (Aditya, Ahmedabad, Gujarat, India) approved (Protocol Approval Number: VED/P-08/21/SEPT/2019) and monitored the study. The study was prospectively registered with the National Institutes of Health clinical trials registry (NCT04117490; Oct 7, 2019). The trial procedures followed were in accordance with the ethical standards of the Helsinki Declaration of 1975, as revised in 2000.